How to Prevent Cognitive Decline

Cognitive decline is not inevitable. Some slowing of processing speed and working memory is a normal part of aging — see how intelligence changes across the lifespan for the typical trajectory — but the rate of decline varies enormously between people, and most of that variance is driven by modifiable factors. The 2024 update of the Lancet standing Commission on dementia prevention identified 14 such factors that, taken together, account for an estimated 45% of dementia risk worldwide (Livingston et al., 2024). What follows is what the evidence actually supports — and what it does not.

The Modifiable Factor Framework

The Lancet Commission’s framework matters because it sets the realistic ceiling for prevention. Eliminating every modifiable risk factor would not abolish dementia — roughly 55% of risk remains tied to age, genetics (especially APOE ε4), and unknown causes. But shifting the modifiable half is the largest individual lever available, and the interventions are not exotic. They are mostly the same things that protect cardiovascular and metabolic health.

The 2024 update added three new risk factors to the previous 12-factor framework (Livingston et al., 2020): untreated vision loss, high LDL cholesterol, and a strengthened weight on hearing loss. The strongest individual contributors remain hearing loss in midlife, education in early life, and physical inactivity. Below, the interventions are ordered by the consistency and rigor of the supporting trials, not by their headline appeal.

Physical Exercise: The Most Powerful Single Intervention

If a pill produced what aerobic exercise produces — improved memory and executive function, reduced depression, slowed brain atrophy, and a 30–40% reduction in dementia risk — it would be the most prescribed medication in history. The evidence base is enormous and consistent.

The Northey et al. (2018) systematic review and meta-analysis pooled 39 randomized trials in adults over 50 and found a small-to-moderate overall effect of exercise on cognition (standardized mean difference = 0.29), with the strongest gains in attention, executive function, and overall cognition. Aerobic exercise, resistance training, multicomponent programs, and tai chi all showed benefit; the recommended dose was moderate-to-vigorous activity for 45–60 minutes per session on most days.

The Erickson et al. (2011) PNAS trial showed why this works at the structural level: 120 sedentary older adults randomized to a year of moderate aerobic exercise gained roughly 2% in anterior hippocampal volume, effectively reversing 1–2 years of typical age-related atrophy, while the stretching control group lost volume as expected. Spatial memory tracked the volume change.

For most adults, the threshold dose is 150 minutes per week of moderate-intensity aerobic activity (brisk walking, cycling, swimming) plus two or three weekly resistance sessions. Cognitively demanding “open-skill” exercise — racket sports, dance, martial arts that require dynamic decision-making — appears to produce somewhat larger effects on inhibitory control and cognitive flexibility than predictable closed-skill activity at matched intensity (Yamasaki, 2023). For deeper coverage of the chronic-training literature, see how regular exercise affects long-term brain health.

Cardiovascular Risk Management

What is good for the heart is good for the brain. Hypertension, diabetes, high LDL cholesterol, and central obesity are all independent risk factors for cognitive decline and vascular contributions to dementia. Cerebral blood flow depends on a vast vascular network, and the small-vessel disease that follows decades of poorly controlled cardiovascular risk produces white matter lesions, microinfarcts, and accelerated atrophy long before symptoms appear.

The clearest randomized evidence comes from the SPRINT MIND trial (Williamson et al., 2019). In 9,361 hypertensive adults aged 50+, intensive blood pressure control (target systolic < 120 mmHg) reduced the risk of mild cognitive impairment by 19% over a median 5.1 years compared with standard treatment (target < 140 mmHg). The dementia endpoint did not reach statistical significance — likely because the trial was stopped early for the cardiovascular benefit, leaving too few dementia events. The MCI signal is the most robust randomized evidence to date that vascular treatment moves cognitive outcomes.

Midlife (roughly 40–65) appears to be the critical window. Hypertension control before 65 predicts late-life cognition more reliably than control after symptoms appear.

Sleep Quality and Sleep-Disordered Breathing

During slow-wave sleep, the glymphatic system clears metabolic waste from the brain, including soluble beta-amyloid. Chronic sleep restriction impairs this clearance, and observational studies link both short and fragmented sleep to elevated amyloid burden. The clinical implication: acute sleep deprivation hurts cognitive performance, and chronic disruption appears to compound across years.

Sleep-disordered breathing is the under-recognized risk. In the Yaffe et al. (2011) JAMA cohort of 298 community-dwelling older women, those with sleep-disordered breathing had roughly 1.85 times the odds of developing mild cognitive impairment or dementia over five years compared with those without — and the effect was driven by the hypoxia component, not arousal frequency. CPAP treatment can improve cognitive performance and may modify dementia trajectory, but adherence is the practical limit. Anyone with loud snoring, witnessed apneas, or daytime sleepiness should be screened.

Diet: The Mediterranean and MIND Patterns

The observational evidence for Mediterranean-style and MIND (Mediterranean–DASH Intervention for Neurodegenerative Delay) eating patterns is consistent and large. Morris et al. (2015) reported that high adherence to the MIND diet was associated with a 53% lower Alzheimer’s risk over 4.5 years in 923 older adults, with moderate adherence still cutting risk by 35%.

The randomized evidence is less flattering. Barnes et al. (2023) randomized 604 older adults to either a calorie-restricted MIND diet or a calorie-restricted control diet for three years. Both groups showed improved cognition; there was no significant between-group difference. The likely reason is that the control arm was high-quality (intentional weight loss with dietary counseling), not a junk-food comparator — so the trial tested MIND specifically against generic dietary improvement rather than against a typical diet. Caloric restriction and weight loss may carry most of the cognitive benefit, with specific food choices contributing less than the observational data suggested.

The actionable signal: any diet that produces sustained cardiovascular and metabolic improvement appears protective. Mediterranean and MIND patterns are well-tolerated, evidence-supported scaffolds. The food details matter less than adherence. For the broader case, see Mediterranean diet and brain health.

Cognitive Engagement: Novelty Required

Continued cognitive engagement builds cognitive reserve — the neural capacity that lets brains tolerate pathology before showing symptoms. Education, occupational complexity, and effortful leisure activities all predict slower decline.

The catch is that the engagement must be genuinely challenging and novel. Repeating familiar tasks maintains existing skill but does not build new capacity. The ACTIVE trial (Rebok et al., 2014) followed 2,832 older adults for ten years after brief cognitive training in reasoning, memory, or speed of processing. Trained tasks improved and the gains held, but transfer to untrained everyday tasks was modest, and the speed-of-processing arm was the only group with measurable real-world functional benefit at follow-up.

The implication is that commercial brain-training apps, which optimize for trained-task performance, are likely a poor use of time. Learning a language, taking up an instrument, studying an unfamiliar field, or playing complex strategic games against varied opponents provides the kind of effortful novelty the ACTIVE results imply is necessary.

Social Connection

Social isolation is now treated as a dementia risk factor on par with smoking. Holt-Lunstad et al. (2015) meta-analyzed 70 prospective studies and reported that social isolation raised mortality risk by 29%, loneliness by 26%, and living alone by 32% — comparable to physical inactivity and obesity. The Lancet Commission attributes about 4% of population-level dementia risk to infrequent social contact specifically.

The mechanisms layer: social interaction is itself complex cognitive work (language, perspective-taking, memory retrieval), social support buffers chronic stress and cortisol exposure, and connected people exercise more and adhere to medical care better. Chronic loneliness accelerates hippocampal atrophy through pathways that overlap with chronic stress effects on the brain.

What Does Not Work

Several heavily marketed interventions lack convincing randomized evidence for cognitive protection in adults without documented deficiency.

Supplements. Vitamin E, B-vitamin combinations, ginkgo biloba, and omega-3 supplements have produced null results in well-powered randomized trials of cognitively healthy older adults. Correcting genuine deficiencies (B12, vitamin D, iron) is appropriate; supplementing without a deficiency is not preventive.

Hormone replacement therapy initiated in late menopause does not protect cognition and may modestly elevate dementia risk in some populations.

Commercial brain-training apps reliably improve trained-task performance and rarely transfer to other domains, as the ACTIVE trial showed even with carefully designed in-person training.

Two preventable contributors are easier to ignore than they should be: alcohol consumption above moderate levels accelerates atrophy, and long-term fine particulate exposure adds measurable dementia risk. Both are on the Lancet Commission list and both are addressable.

The Practical Sequence

If the question is what to do first, the answer is consistent across the trial literature. Treat blood pressure aggressively in midlife. Exercise 150 minutes a week with at least some vigorous and some resistance work. Address sleep — get screened for sleep-disordered breathing if there is any indication. Eat a Mediterranean-pattern diet at sustainable adherence. Stay socially active, and choose cognitive activities that are genuinely hard for you. Limit alcohol. The interventions stack: each adds independent risk reduction, and the combination is what produces the Lancet Commission’s 45% theoretical ceiling.

None of this requires special equipment, supplements, or commercial programs. The reason it is hard is not that the prescription is unclear — it is that sustaining the prescription for thirty years is.

Frequently Asked Questions

When should I start preventing cognitive decline?

Midlife — roughly your 40s and 50s — is the highest-leverage window because cardiovascular and lifestyle factors during this period predict late-life cognition more reliably than the same factors after 65. That said, the trial evidence shows benefits at every age tested, including in adults already showing early cognitive symptoms. Starting later is less effective than starting earlier, but it is not too late.

Do crossword puzzles and Sudoku prevent dementia?

They maintain the specific verbal or numerical skill being practiced and have not been shown to reduce dementia risk in randomized trials. The ACTIVE trial showed that even structured cognitive training transfers narrowly. For cognitive reserve, novel and effortful learning — a new language, an instrument, an unfamiliar subject — is more likely to produce benefit than repeating familiar puzzles.

Are commercial brain-training apps worth the subscription?

The randomized evidence is consistently weak. Trained-task performance improves; transfer to unrelated cognitive function and to real-world outcomes is minimal. Time spent on a brain-training app would, on the available evidence, produce more cognitive benefit if redirected to physical exercise or learning something new.

How much does genetics determine my risk?

APOE ε4 is the largest common genetic risk factor for late-onset Alzheimer’s disease — one copy roughly triples risk and two copies raise it about 8–12 times. But APOE status does not determine outcome. The Lancet Commission’s modifiable-factor estimate (45% of dementia risk) applies to APOE ε4 carriers as well; lifestyle interventions remain effective and arguably more important in higher-risk individuals.

Is there a single most important thing to do?

Aerobic exercise has the strongest randomized evidence base across cognitive outcomes, structural brain measures, and dementia incidence. If only one intervention is sustainable, that is the one with the most consistent return. The full prescription is more effective than any single component, but exercise is the lever with the best supporting trials.